{
  "abstract": "The World Health Organization and the National Advisory Committee on Immunization now recommend a single-dose HPV vaccine schedule for most immunocompetent adolescents. As Canadian jurisdictions transition to a single-dose schedule, we apply a social and behavioral science lens and draw on lessons from previous vaccine schedule changes and international experience to identify potential challenges and opportunities associated with this transition. Key implementation considerations include maintaining public confidence through transparent communication about the rationale for the schedule change, ensuring healthcare providers, immunizers, and parents are adequately prepared to support the transition, and promoting equitable access through robust catch-up programs and targeted outreach initiatives. Attention to these factors will be critical to supporting successful implementation of single-dose HPV vaccination programs in Canada.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network (UHN), Toronto, Canada.",
    "Department of Anthropology, Laval University, Québec City, Canada.",
    "Department of Psychiatry and Dalla Lana School of Public Health, University of Toronto, Toronto, Canada."
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 4,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Madison Leggatt",
      "orcid": "0009-0001-9640-7918"
    },
    {
      "affs": [
        0
      ],
      "name": "Nivatha Moothathamby",
      "orcid": "0000-0003-1222-6157"
    },
    {
      "affs": [
        1
      ],
      "name": "Ève Dubé",
      "orcid": "0000-0003-1336-1510"
    },
    {
      "affs": [
        0,
        2
      ],
      "name": "Gilla K Shapiro",
      "orcid": "0000-0002-2214-8263"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/a92d3j63f5jsa.bib",
  "cited_by": 0,
  "doi": "10.1080/21645515.2026.2749306",
  "fulltext_url": "https://europepmc.org/articles/PMC13685554",
  "id": "a92d3j63f5jsa",
  "issns": [
    "2164-5515",
    "2164-554X"
  ],
  "landing_url": "https://europepmc.org/article/MED/42899377",
  "language": "eng",
  "licence": "CC-BY-NC",
  "licence_label": "CC BY-NC",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "openalex",
      "2713|Cervical Cancer and HPV Research"
    ]
  ],
  "openalex": "W7223050947",
  "pdf_url": "https://europepmc.org/articles/PMC13685554?pdf=render",
  "pmcid": "PMC13685554",
  "pmid": "42899377",
  "published": "2026-10-20",
  "publisher": null,
  "ris": "https://research.draconitic.com/paper/a92d3j63f5jsa.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:19:32Z",
      "native_id": "MED:42899377",
      "source": "europepmc",
      "url": "https://europepmc.org/article/MED/42899377"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2713|Cervical Cancer and HPV Research",
      "subfield": "epidemiology-public-health"
    }
  ],
  "title": "Implementing single-dose HPV vaccination in Canada.",
  "title_text": "Implementing single-dose HPV vaccination in Canada.",
  "type": "peer-reviewed",
  "updated_at": "2026-10-30T12:19:32Z",
  "url": "https://research.draconitic.com/paper/a92d3j63f5jsa",
  "venue": "Human vaccines & immunotherapeutics",
  "versions": []
}